Evidence map›Paper›PMID 26069793›Full record

ArticleClinical kidney journal2012

Mucormycosis (zygomycosis) of renal allograft.

Krishan L Gupta, Kusum Joshi, Harbir S Kohli, Vivekanand Jha, Vinay Sakhuja

Open access · bronzeAbstract read
In one paragraph

Article in Clinical kidney journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Donor-derived renal allograft mucormycosis in a combined liver and kidney transplantation: Case report and review of the literature.Transplant infectious disease : an official journal of the Transplantation Society · 2021
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Krishan L GuptaDepartment of Nephrology , Institute of Medical Education and Research , Chandigarh 160 012 , India.
Kusum JoshiDepartment of Pathology , Postgraduate Institute of Medical Education and Research , Chandigarh 160 012 , India.
Harbir S KohliDepartment of Nephrology , Institute of Medical Education and Research , Chandigarh 160 012 , India.
Vivekanand JhaDepartment of Nephrology , Institute of Medical Education and Research , Chandigarh 160 012 , India.
Vinay SakhujaDepartment of Nephrology , Institute of Medical Education and Research , Chandigarh 160 012 , India.
Post Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal infection is relatively common among renal transplant recipients from developing countries. Mucormycosis, also known as zygomycosis, is one of the most serious fungal infections in these patients. The most common of presentation is rhino-cerebral. Isolated involvement of a renal allograft is very rare. A thorough search of literature and our medical records yielded a total of 24 cases with mucormycosis of the transplanted kidney. There was an association with cytomegalovirus (CMV) infection and anti-rejection treatment in these patients and most of these transplants were performed in the developing countries from unrelated donors. The outcome was very poor with an early mortality in 13 (54.5%) patients. Renal allograft mucormycosis is a relatively rare and potentially fatal complication following renal transplantation. Early diagnosis, graft nephrectomy and appropriate antifungal therapy may result in an improved prognosis for these patients.

Indexed as

cytomegalovirus infectionimmunosuppressionmucormycosisrenal allograft

Identifiers

PMID26069793
PMCPMC4400555
OpenAlexW2130678055

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.